Johnson & Johnson (FRA:JNJ) Margin of Safety % (DCF Earnings Based): -100.32% (As of Jun. 25, 2026)


FRA:JNJ Johnson & Johnson FRA:JNJ
81 GF Score
Price €210.80
GF Value €166.66
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Margin of Safety % (DCF Earnings Based)?

Johnson & Johnson FRA:JNJ +1.20% 81 Margin of Safety % (DCF Earnings Based) is -100.32% as of Jun. 25, 2026. GuruFocus rates FRA:JNJ with a GF Score™ of 81/100 and a GF Value™ of €166.66 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-25), Johnson & Johnson's Predictability Rank is 2.5-Stars. Johnson & Johnson's intrinsic value calculated from the Discounted Earnings model is €105.23 and current share price is €210.80. Consequently,

Johnson & Johnson's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -100.32%.


FRA:JNJ vs ABBV, MRK, AMGN: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Margin of Safety % (DCF Earnings Based) falls into.


FRA:JNJ
81GF Score
Johnson & Johnson FRA:JNJ
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Margin of Safety % (DCF Earnings Based) Calculation

Johnson & Johnson's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(105.23-210.80)/105.23
=-100.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of -100.32% mean?
Johnson & Johnson (FRA:JNJ) has a Margin of Safety % (DCF Earnings Based) of -100.32% as of Jun. 25, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Johnson & Johnson.
Is Johnson & Johnson's Margin of Safety % (DCF Earnings Based) too high?
Johnson & Johnson's current Margin of Safety % (DCF Earnings Based) is -100.32%. Overall, Johnson & Johnson has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Margin of Safety % (DCF Earnings Based) compare to ABBV and MRK?
Johnson & Johnson's Margin of Safety % (DCF Earnings Based) of -100.32% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF Earnings Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Johnson & Johnson. Johnson & Johnson's current Margin of Safety % (DCF Earnings Based) is -100.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (FRA:JNJ) is currently considered Modestly Overvalued. The stock's GF Value™ is €166.66, compared to a current price of €210.80 — trading 26.5% above its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is -100.32%. Johnson & Johnson's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Johnson & Johnson (FRA:JNJ), the current Margin of Safety % (DCF Earnings Based) is -100.32% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (FRA:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of €210.80 is trading 26.5% above its estimated GF Value™ of €166.66. GuruFocus considers Johnson & Johnson to be Modestly Overvalued.

Key valuation signals for FRA:JNJ:

  • Margin of Safety % (DCF Earnings Based): -100.32%
  • GF Value™: €166.66 vs. price of €210.80 (26.5% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the FRA:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
81GF Score

Get the complete analysis for FRA:JNJ

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€210.80
Price
€166.66
GF Value